Format

Send to

Choose Destination
Indian J Nephrol. 2008 Jan;18(1):31-9. doi: 10.4103/0971-4065.41289.

Revised guidelines for management of steroid-sensitive nephrotic syndrome.

Author information

1
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Abstract

JUSTIFICATION:

In 2001, the Indian Pediatric Nephrology Group formulated guidelines for management of patients with steroid-sensitive nephrotic syndrome. In view of emerging scientific evidence, it was felt necessary to review the existing recommendations.

PROCESS:

Following a preliminary meeting in March 2007, a draft statement was prepared and circulated among pediatric nephrologists in the country to arrive at a consensus on the evaluation and management of these patients.

OBJECTIVES:

To revise and formulate recommendations for management of steroid-sensitive nephrotic syndrome.

RECOMMENDATIONS:

The need for adequate corticosteroid therapy at the initial episode is emphasized. Guidelines regarding the initial evaluation, indications for renal biopsy and referral to a pediatric nephrologist are updated. It is proposed that patients with frequently relapsing nephrotic syndrome should, at the first instance, be treated with longterm, alternate-day prednisolone. The indications for use of alternative immunosuppressive agents, including levamisole, cyclophosphamide, mycophenolate mofetil, and cyclosporin are outlined. The principles of dietary therapy, management of edema, and prevention and management of complications related to nephrotic syndrome are described. These guidelines, formulated on the basis of current best practice, are aimed to familiarize physicians regarding principles of management of children with steroid-sensitive nephrotic syndrome.

KEYWORDS:

Nephrotic syndrome; practice guidelines; recommendations

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center